Key result
Every U.S.$100 less spent during the index hospitalization for acute myocardial infarction was associated with a 0.63% increase in the hazard of dying and a 1.24% increase in readmission hazard.
Why the study?
Is there a relationship between hospital costs and health outcomes (mortality and readmission) for patients with acute myocardial infarction?
Observational
Yes
Is there a relationship between hospital costs and health outcomes (mortality and readmission) for patients with acute myocardial infarction?
Effect estimate: 0.63% increase in hazard of dying and 1.24% increase in hazard of readmission per $100 less spent
Lower hospital spending during the index admission for acute myocardial infarction is associated with increased 1-year mortality and readmission rates.
Raises caution on cost containment in AMI care; hypothesis-generating and should not yet alter practice.
OBJECTIVE: To investigate and to quantify the relationship between hospital costs and health outcomes for patients with acute myocardial infarction (AMI) in Veterans Health Administration (VHA) hospitals using individual-level data for costs and outcomes. DATA SOURCES: VHA administrative files for the fiscal years 2000-2006. STUDY DESIGN: Costs were defined as costs incurred during the index hospitalization for treatment of AMI. Mortality and readmission, assessed 1 year after the index hospitalization, were used as measures of clinical outcome. We examined health outcomes as a function of costs and other patient-level and hospital-level characteristics using a two-stage Cox proportional hazard model that accounted for competing risks within a multilevel framework. To control for patient comorbidities, we compiled a comprehensive list of comorbidities that have been found in other studies to affect mortality and readmissions. PRINCIPAL FINDINGS: We found that costs were negatively associated with mortality and readmissions. Every U.S.$100 less spent is associated with a 0.63 percent increase in the hazard of dying and a 1.24 percent increase in the hazard to be readmitted conditional on not dying. This main finding remained unchanged after a number of sensitivity checks. CONCLUSIONS: Our results suggest that there is a trade-off between costs and outcomes. The negative association between costs and mortality suggests that outcomes should be monitored closely when introducing cost-containment programs. Additional studies are needed to examine the cost-outcome relationship for conditions other than AMI to see whether our results are consistent.
No takes yet. Share an insight, caveat, or question.
Schreyögg et al. (2010) conducted an observational in Acute myocardial infarction. Lower hospital costs vs. Higher hospital costs was evaluated on Mortality and readmission at 1 year (0.63% increase in hazard of dying and 1.24% increase in hazard of readmission per $100 less spent). Every U.S.$100 less spent during the index hospitalization for acute myocardial infarction was associated with a 0.63% increase in the hazard of dying and a 1.24% increase in readmission hazard.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: